Ernesto Montero-Zeledón
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ernesto Montero-Zeledón has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adrián Flores
CEQIATEC Research Center. School of Chemistry, Costa Rica Institute of Technology, Cartago, 30101, Cartago, Costa Rica
1 shared publication - Alejandro Medaglia-Mata
Centro de Investigación en Biotecnología, Escuela de Biología, Instituto Tecnológico de Costa Rica, Cartago 30101, Costa Rica
1 shared publication - Andrea Mariela Araya-Sibaja
LANOTEC, Centro Nacional de Alta Tecnología, San Jose, Costa Rica, Costa Rica
1 shared publication - Ariadna Abdala-Saiz
Departamento de Investigación y Desarrollo, Calox de Costa Rica, San José 126224-01, Costa Rica
1 shared publication - José Roberto Vega-Baudrit
LANOTEC, Centro Nacional de Alta Tecnología, San Jose, Costa Rica, Costa Rica
1 shared publication - Luis Alejandro Gómez Vargas
Instituto Tecnológico de Costa Rica
1 shared publication
Latest Publications
- Open Access
- 8 August 2023
- Published by Elsevier in Environmental Research
- Vol. 237, 116843
Human health risk assessment for consumption of microplastics and plasticizing substances through marine species
- 8 August 2023
- Published by Elsevier in Environmental Research
- Vol. 237, 116843
Open AccessHuman health risk assessment for consumption of microplastics and plasticizing substances through marine species
- Open Access
- 16 February 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (2) , 424
Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
A drug–drug and drug–excipient interactions and compatibilities study was conducted for two fixed-dose combination (FDC) products containing olmesartan medoxomil (OLM)/hydrochlorothiazide (HCT) 20/12.5 mg and OLM/HCT 40/12.5 mg during their development including storage. The study consisted of the evaluation of samples retrieved during all stages of a real manufacturing process. Powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), thermogravimetry (TGA), Fourier transform infrared spectroscopy (FT-IR), and contact angle techniques were applied to the samples to determine interactions and incompatibilities. Dissolution tests and long-term stability studies were conducted to evaluate dosage form performance. Results showed weak solid–state interactions able to obtain a eutectic mixture of OLM and HCT while microcrystalline cellulose (MC) impacted the thermal stability of both drugs. Reliable dissolution and long-term stability tests confirmed that the interactions observed were not considered incompatibilities because they were not influenced by the performance of the final products.
- 16 February 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (2) , 424
Open AccessInteraction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process
A drug–drug and drug–excipient interactions and compatibilities study was conducted for two fixed-dose combination (FDC) products containing olmesartan medoxomil (OLM)/hydrochlorothiazide (HCT) 20/12.5 mg and OLM/HCT 40/12.5 mg during their development including storage. The study consisted of the evaluation of samples retrieved during all stages of a real manufacturing process. Powder X-ray diffraction (PXRD), differential scanning calorimetry (DSC), thermogravimetry (TGA), Fourier transform infrared spectroscopy (FT-IR), and contact angle techniques were applied to the samples to determine interactions and incompatibilities. Dissolution tests and long-term stability studies were conducted to evaluate dosage form performance. Results showed weak solid–state interactions able to obtain a eutectic mixture of OLM and HCT while microcrystalline cellulose (MC) impacted the thermal stability of both drugs. Reliable dissolution and long-term stability tests confirmed that the interactions observed were not considered incompatibilities because they were not influenced by the performance of the final products.